Benjamin H. Blehm, PhD, serves as the Chief Executive Officer at Darya Pharmaceuticals. He is dedicated to building a nimble and innovative radiopharmaceutical contract research organization. He draws from a rich background that includes leading large-scale diagnostic instrumentation projects at Roche and providing strategic consulting to medical device startups. Ben brings extensive experience in systems engineering, regulatory strategy, and forward-thinking leadership. He is passionately committed to positioning Darya Pharmaceuticals at the forefront of radiopharmaceutical innovation, ensuring we deliver exceptional value and groundbreaking solutions to our partners.

Ben holds a PhD in Physics from the University of Illinois, Urbana-Champaign.